Monitoring blood glucose is a painful ritual for diabetics. Now, however, noninvasive measurement is possible (pages 1198–1201).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
The Diabetes Control and Complications Trial Research Group. New Engl. J. Med. 329, 977–986 (1993).
O'Driscoll, C. Injecting new ideas. Chem. Brit. 30, 878–880 (1994).
Heller, J. The use of enzyme-substrate reactions in the design of self-regulated drug delivery systems. in Pulsatile Drug Delivery, Current Applications and Future Trends (eds Gurny, R., Junginger, H.E. & Peppas, N.A.) 57–71 (Wissenschaftliche Verlagsgesellschaft, Stuttgart, 1993).
Tamada, J.A., Bohannon, N.J.V., Potts, R.O. Measurement of glucose in diabetic subjects using noninvasive transdermal extraction. Nature Med., 1, 1198–1201 (1995).
Burnette, R.R., Iontophoresis. in Transdermal Drug Delivery: Developmental Issues and Research initiatives, (eds Hadgraft, J., Guy, R.H.) 247–291 (Marcel Dekker, New York, 1989).
Leduc, S. Les Ions et les médications ioniques. (Masson, Paris, 1907).
Pikal, M.J. The role of electroosmotic flow in transdermal iontophoresis. Adv. Drug Deliv. Rev. 9, 201–237 (1992).
Glikfeld, P., Hinz, R.S. & Guy, R.H. Noninvasive sampling of biological fluids by iontophoresis. Pharmac. Res. 6, 988–990 (1989).
Rao, G., Glikfeld, P. & Guy, R.H. Reverse iontophoresis: Development of a noninvasive approach for glucose monitoring. Pharmac. Res. 10, 1751–1755 (1993).
Santi, P. & Guy, R.H. Reverse iontophoresis — Parameters determining electroosmotic flow: I. pH and ionic strength. J. Control. Release (in the press).
Rao, G. et al. Reverse iontophoresis: Noninvasive glucose monitoring in vivo in humans. Pharmac. Res. (in the press).
Guy, R.H. et al. Method for the iontophoretic non-invasive determination of the in vivo concentration level of an inorganic or organic substance. U.S. Patent # 5,362,307 (1994).
Turner, A.P.F. (ed.) Chemical Sensors for In Vivo Monitoring. (JAI Press, London, 1993).
Ledger, P.W. Skin biological issues in electrically enhanced transdermal delivery. Adv. Drug Deliv. Rev. 9, 289–307 (1992).
Amato, I. Race quickens for non-stick blood monitoring technology. Science 258, 892–893 (1992).
Mitragotri, S., Blankschtein, D. & Langer, R. Ultrasound-mediated transdermal protein delivery. Science 269, 850–853 (1995).
Tachibana, K. Transdermal delivery of insulin to alloxan-diabetic rabbits by ultrasound exposure. Pharmac. Res. 9, 952–954 (1992).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Guy, R. A sweeter life for diabetics?. Nat Med 1, 1132–1133 (1995). https://doi.org/10.1038/nm1195-1132
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm1195-1132
This article is cited by
-
Transdermal delivery of peptides by iontophoresis
Nature Biotechnology (1996)
-
Recent developments in topical and transdermal delivery
European Journal of Drug Metabolism and Pharmacokinetics (1996)